MO - Altria Group, Inc.

NYSE - NYSE Delayed Price. Currency in USD
53.92
+0.59 (+1.11%)
At close: 4:02PM EST
Stock chart is not supported by your current browser
Previous Close53.33
Open53.36
Bid0.00 x 2900
Ask0.00 x 800
Day's Range53.23 - 54.10
52 Week Range52.73 - 74.38
Volume8,119,954
Avg. Volume8,616,459
Market Cap101.318B
Beta (3Y Monthly)-0.14
PE Ratio (TTM)9.58
EPS (TTM)N/A
Earnings DateN/A
Forward Dividend & Yield3.20 (5.91%)
Ex-Dividend Date2018-09-13
1y Target EstN/A
Trade prices are not sourced from all markets
  • The Wall Street Journal6 hours ago

    [$$] Juul’s Soaring Valuation Is a Boon for Hedge Funds

    Several large investment firms are sitting on windfalls from e-cigarette maker Juul Labs Inc.—and plan to continue backing the controversial startup despite the risk of increased regulation. Tiger Global Management LLC, Darsana Capital Partners LP, D1 Capital Partners LP, Marianas Fund Management LLC and Coatue Management LLC have invested in Juul at various points over the last two years. Juul has rapidly appreciated in value, rising to a roughly $16 billion valuation last summer.

  • InvestorPlace12 hours ago

    Why Aurora Cannabis Stock Will Drop Back Under $5

    It’s been an exciting couple of weeks for the marijuana industry in general and Aurora Cannabis (NYSE:ACB) in particular. This week, Aurora announced a new acquisition in Mexico that sent ACB stock significantly higher. Will Aurora be next?… Probably not.

  • InvestorPlace17 hours ago

    3 Reasons Why You Shouldn’t Panic About Cronos Stock

    Case in point is Altria Group’s (NYSE:MO) $1.8 billion equity investment in Cronos Group (NASDAQ:CRON). The move features many positive implications, not the least of which is a massive boost for CRON stock. When the deal made headlines, Cronos stock jumped nearly 22% against the prior day’s close.

  • Altria Group Declares Quarterly Dividend
    GuruFocus.com15 hours ago

    Altria Group Declares Quarterly Dividend

    The U.S. tobacco giant Altria Group Inc. (MO) announced Wednesday that holders of the common stock will receive an 80-cent cash quarterly dividend per share on Jan. 10, 2019. Warning! GuruFocus has detected 3 Warning Sign with AAPL. If held constant, the cash quarterly dividend of 80 cents totals an annual payment of $3.20 per ordinary share, for a forward dividend yield of 6%.

  • 4 Reasons Why Pot Stocks & ETF Could Be on a High in 2019
    Zacks18 hours ago

    4 Reasons Why Pot Stocks & ETF Could Be on a High in 2019

    These are the factors that could send marijuana stocks and ETF high in 2019.

  • Analysts Still Favor a ‘Buy’ on Altria and Philip Morris
    Market Realist19 hours ago

    Analysts Still Favor a ‘Buy’ on Altria and Philip Morris

    Will 2019 Be Better for Altria and Philip Morris? Of the 17 analysts that follow Altria Group (MO), 58.8% are favoring a “buy,” and 41.2% are favoring a “hold.” There aren’t any “sell” ratings on the stock. On December 7, Barclays initiated coverage on Altria with an “overweight” rating and a target price of $64.

  • InvestorPlace2 days ago

    Will Coca-Cola Stock Be the Next Giant to Fall?

    From here, Coca-Cola (NYSE:KO) looks badly overvalued. Coca-Cola stock is a classic long-term play, seemingly, but that alone doesn’t justify a stretched valuation. KO stock touched an all-time high just a couple of weeks ago.

  • Altria and Philip Morris: Do Dividend Yields Look Attractive?
    Market Realist2 days ago

    Altria and Philip Morris: Do Dividend Yields Look Attractive?

    Will 2019 Be Better for Altria and Philip Morris? Dividends help smooth out return volatility for shareholders. Both Philip Morris International (PM) and Altria Group (MO) have a strong history of returning cash to shareholders.

  • What to Expect from Philip Morris’s Revenue in 2019
    Market Realist2 days ago

    What to Expect from Philip Morris’s Revenue in 2019

    Analysts expect Philip Morris International’s (PM) revenue to rise by 2.7% to $29.54 billion in 2018. They expect the company’s revenue for 2019 to be at $30.33 billion, which represents YoY growth of 2.7% from 2018.

  • 3 Dividend Stocks That Pay You More Than Exxon Does
    Motley Fool2 days ago

    3 Dividend Stocks That Pay You More Than Exxon Does

    Looking for big yield? ExxonMobil has it, but these three stocks should also be on your radar.

  • Why Are Analysts Expecting Altria’s Revenue to Rise in 2019?
    Market Realist2 days ago

    Why Are Analysts Expecting Altria’s Revenue to Rise in 2019?

    Will 2019 Be Better for Altria and Philip Morris? Analysts are expecting Altria Group’s (MO) revenue to rise by 0.9% to $19.66 billion in 2018, while its revenue in 2019 is expected to increase by 1.5% to $19.95 billion. What will drive Altria’s sales?

  • Barrons.com2 days ago

    Altria Might Have a Plan for a Cigarette-Free Future

    Altria’s announcement that it would invest in Canadian marijuana company Cronos Group got all the attention, but one analyst describes its decision to discontinue its own vaping products as “savvy.”

  • CNBC2 days ago

    Cramer Remix: Don't waste your time with sector-based ETFs

    Jim Cramer uses the tech sector to make a case for picking individual stocks over risky exchange-traded funds.

  • Altria (MO) Gains As Market Dips: What You Should Know
    Zacks2 days ago

    Altria (MO) Gains As Market Dips: What You Should Know

    Altria (MO) closed the most recent trading day at $53.95, moving +1.11% from the previous trading session.

  • Canopy Growth still best way to play Canadian cannabis even with Cronos-Altria deal: Cramer
    CNBC2 days ago

    Canopy Growth still best way to play Canadian cannabis even with Cronos-Altria deal: Cramer

    Jim Cramer continues to back Canopy Growth Corp. as the best way to invest in the growing Canadian cannabis space after tobacco giant Altria invests in its rival, Cronos Group.

  • Altria Beats Philip Morris’s EPS Growth in First Three Quarters
    Market Realist2 days ago

    Altria Beats Philip Morris’s EPS Growth in First Three Quarters

    Will 2019 Be Better for Altria and Philip Morris? In the first three quarters of 2018, Altria Group (MO) posted adjusted EPS of $3.04, which represents growth of 22.6% from $2.48 in the corresponding three quarters of the previous year. Also, the company has outperformed analysts’ EPS expectations in all three quarters.

  • Why New Age Beverages Stock Spiked Today
    Motley Fool2 days ago

    Why New Age Beverages Stock Spiked Today

    Shares of the CBD beverage maker picked up steam for the second day in a row. Here's why.

  • Canopy Growth (CGC) Gains on Hemp Legalization, Institutional Interest
    Zacks2 days ago

    Canopy Growth (CGC) Gains on Hemp Legalization, Institutional Interest

    Shares of Canopy Growth (CGC) were up more than 6% in late afternoon trading Tuesday, as investors expressed optimism about the Senate's hemp legalization bill and management's comments about interest from institutional investors.

  • Philip Morris Has Outperformed Altria’s Revenue Growth in 2018
    Market Realist2 days ago

    Philip Morris Has Outperformed Altria’s Revenue Growth in 2018

    Will 2019 Be Better for Altria and Philip Morris? In the first three quarters of 2018, Philip Morris International (PM) posted net revenue growth of 8.2%, outperforming Altria Group’s (MO) net revenue growth of 0.4%. During the period, Philip Morris posted net revenue of $22.13 billion compared to $20.45 billion in the first three quarters of 2017.

  • 12 Stocks You Should Never Sell
    Kiplinger2 days ago

    12 Stocks You Should Never Sell

    Hopping in and out of stocks tends to do more harm than good to your portfolio. Fortunately, most of the time, investors are content to sit back and let time do the heavy lifting. Every now and then, however, an uninterrupted market-wide rally (such as the one we saw in 2017) followed by a couple of major corrections (such as the ones we've seen in 2018) inspires a more active approach. Buying every dip last year was a bulletproof strategy; steering clear of this year's big dips would've left most investors far better off. But broadly speaking, investors shouldn't embrace that short-term mindset. Buy-and-hold is a time-tested strategy that helps investors avoid trying to time the market (which even experts can't reliably do) and making poor emotional decisions. With that as a backdrop, here are a dozen stocks to never sell. Many buy-and-holders are looking to reset their portfolios as the new year begins. If you hold any of the stocks, don't stop ... and if you're looking to buy, be ready to commit. Each company has plenty to success that their history of success should continue for years to come. And each operates in an industry that won't go away anytime soon. SEE ALSO: 101 Best Dividend Stocks to Buy for 2019 and Beyond

  • InvestorPlace3 days ago

    Did Altria Pay Too Much for Cronos Stock?

    Altria Group (NYSE:MO) is joining the mega-cap firms eager to hedge against a potential decline in their home business. On Dec. 7, the firm said it would invest a $1.8 billion stake in Cronos Group (NASDAQ:CRON). Meanwhile, Constellation Brands (NYSE:STZ) bought Canopy Growth (NYSE:CGC) at the beginning of this year.

  • Can We Expect Upward Momentum in Altria and Philip Morris?
    Market Realist2 days ago

    Can We Expect Upward Momentum in Altria and Philip Morris?

    Will 2019 Be Better for Altria and Philip Morris? 2018 has been tough for tobacco companies. The increased anti-tobacco regulations, the declining smoking population, and the rising competition in the RRP (reduced-risk products) space have been putting pressure on tobacco companies.

  • Canopy Growth best way to play Canadian cannabis
    CNBC Videos2 days ago

    Canopy Growth best way to play Canadian cannabis

    Jim Cramer continues to back Canopy Growth Corp. as the best way to invest in the growing Canadian cannabis space after tobacco giant Altria invests in its rival, Cronos Group.

  • Canopy Growth still best way to play Canadian cannabis ev...
    CNBC Videos2 days ago

    Canopy Growth still best way to play Canadian cannabis ev...

    Jim Cramer continues to back Canopy Growth Corp. as the best way to invest in the growing Canadian cannabis space after tobacco giant Altria invests in its rival, Cronos Group.